Trials / Unknown
UnknownNCT02610712
Clinical Trial of the Use of Ketamine in Treatment Resistant Depression
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- National Institute of Neurology and Neurosurgery, Mexico · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the efficacy of the use of intravenous low-dose ketamine in the treatment of treatment-resistant depression (TRD), as well as the changes in Glutamate neurotransmission and inflammatory serum markers.
Detailed description
The purpose of this study is to determine the efficacy of the use of intravenous low-dose ketamine (0.5 mg/kg) in the treatment of treatment-resistant depression (TRD), as well as the changes in Glutamate neurotransmission measured by Magnetic Resonance Imaging Spectroscopy and inflammatory serum markers (IL-6, TNF-alpha).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketamine |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2017-12-01
- First posted
- 2015-11-20
- Last updated
- 2016-09-21
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT02610712. Inclusion in this directory is not an endorsement.